IPHA — INNATE PHARMA S A
As of Q2 2026, 3 SEC-registered investment managers reported holding IPHA (INNATE PHARMA S A) in their latest 13F filings, with a combined reported value of $105.48K across 57.33K shares. That is +5.3% by share count (+2.88K shares) versus the previous quarter, while reported value moved +51.3%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
IPHA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Bank of America Corp history | Q1 2023 | 46.75K | $133.24K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 43.52K | $80.08K | 0.00% | Hold |
| Two Sigma Investments history | Q3 2022 | 18.79K | $38.00K | 0.00% | Reduce |
| Balyasny Asset Management history | Q3 2022 | 16.09K | $32.00K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 12.44K | $22.89K | 0.00% | New |
| Millennium Management history | Q1 2026 | 10.06K | $12.88K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 1.36K | $2.51K | 0.00% | Add |
| Citigroup Inc history | Q4 2022 | 54 | $201 | 0.00% | Hold |
New Positions (Q2 2026)
- Citadel Advisors 12.44K sh · $22.89K
Fully Exited (vs previous quarter)
- Millennium Management sold 10.06K sh · $12.88K
Fund Position History — shares by quarter (top 8 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 17.73K | 39.33K | 44.95K | 46.60K | 56.85K | 49.37K | 48.72K | 47.05K | 44.95K | 46.35K | 44.12K | 43.52K | 43.52K | 43.52K | 43.52K | 51.22K | 53.56K | 46.39K | 43.52K | 43.52K |
| Citadel Advisors | — | — | — | — | — | — | — | 13.28K | — | — | — | 23.53K | 21.27K | 11.85K | 24.27K | 26.62K | 20.04K | — | — | 12.44K |
| UBS Group AG | — | — | — | 2.96K | 4.50K | 146 | 1.26K | 146 | 146 | 146 | 210 | 297 | 8.41K | 3.51K | 9.00K | 5.96K | 4.80K | 947 | 861 | 1.36K |
| Millennium Management | 27.12K | 55.02K | 25.11K | 16.86K | 14.63K | 71.68K | 61.90K | 49.45K | 46.97K | 12.00K | 10.58K | — | — | — | 15.33K | 11.66K | — | 20.31K | 10.06K | — |
| Two Sigma Investments | 18.83K | 67.06K | 36.09K | 25.29K | 18.79K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Balyasny Asset Management | 187.48K | — | — | — | 16.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | 174.10K | 247.05K | 175.18K | 175.23K | 164.78K | 155.79K | 46.75K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | — | 44 | 55 | 55 | 54 | 54 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details